High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery
- 1 December 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 14 (6) , 682-686
- https://doi.org/10.1053/jcan.2000.18328
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The Effects of Aprotinin on Outcome from Cerebral Ischemia in the RatAnesthesia & Analgesia, 1999
- Aprotinin Reduces the Expression of P‐Selectin on the Surface of Platelet and Leukocyte‐Platelet ConjugatesArtificial Organs, 1998
- Pulmonary Effects of Methylprednisolone in Patients Undergoing Coronary Artery Bypass Grafting and Early Tracheal ExtubationAnesthesia & Analgesia, 1998
- Procalcitonin as a Marker of Systemic Inflammation After Conventional or Minimally Invasive Coronary Artery Bypass GraftingThe Thoracic and Cardiovascular Surgeon, 1998
- “Low-Dose” Aprotinin Modifies Hemostasis but Not Proinflammatory Cytokine ReleaseThe Annals of Thoracic Surgery, 1997
- Maintenance of Therapeutic Plasma Aprotinin Levels During Prolonged Cardiopulmonary Bypass Using a Large-Dose RegimenAnesthesia & Analgesia, 1996
- Aprotinin Reduces Interleukin-8 Production and Lung Neutrophil Accumulation After Cardiopulmonary BypassAnesthesia & Analgesia, 1996
- Aprotinin® diminishes inflammatory processesInternational Journal of Cardiology, 1996
- RETRACTED: Circulating adhesion molecules in cardiac operations: Influence of high-dose aprotininThe Annals of Thoracic Surgery, 1995
- Receptor‐Based Pharmacokinetic‐Pharmacodynamic Analysis of CorticosteroidsThe Journal of Clinical Pharmacology, 1993